🇺🇸 Clindamycin Phosphate / Benzoyl Peroxide Gel in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Arthralgia — 1 report (10%)
  2. Chemical Injury — 1 report (10%)
  3. Drug Effect Decreased — 1 report (10%)
  4. Drug Ineffective — 1 report (10%)
  5. Erythema — 1 report (10%)
  6. Gastrointestinal Disorder — 1 report (10%)
  7. Insomnia — 1 report (10%)
  8. Joint Crepitation — 1 report (10%)
  9. Neuropathy Peripheral — 1 report (10%)
  10. Pain Of Skin — 1 report (10%)

Source database →

Other Dermatology approved in United States

Frequently asked questions

Is Clindamycin Phosphate / Benzoyl Peroxide Gel approved in United States?

Clindamycin Phosphate / Benzoyl Peroxide Gel does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Clindamycin Phosphate / Benzoyl Peroxide Gel in United States?

Watson Laboratories, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.